Skip to main content
Erschienen in: Advances in Therapy 12/2020

07.10.2020 | Original Research

Effect of Perindopril/Indapamide on Cerebral Blood Flow in Middle-Aged, Treatment-Naïve Patients with Hypertension

verfasst von: Tatiana M. Ostroumova, Olga D. Ostroumova, Vladimir A. Parfenov, Elena M. Perepelova, Vsevolod A. Perepelov, Alexey I. Kochetkov

Erschienen in: Advances in Therapy | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The relationship between blood pressure (BP) and cerebral blood flow (CBF) is not fully understood. This study evaluated the impact of a perindopril arginine/indapamide (Pa/I) single-pill combination (SPC) on CBF in middle-aged patients.

Methods

A total of 22 treatment-naïve patients with essential hypertension and at least one hypertension-mediated organ damage and 41 healthy controls were enrolled. At baseline, all participants underwent brain magnetic resonance imaging (MRI); patients with hypertension underwent an additional MRI at end of follow-up. Arterial spin labeling (ASL) was used to calculate CBF in the frontal lobe cortical plate. Patients with hypertension received once-daily Pa/I 5 mg/1.25 mg SPC, which could be increased to Pa/I 10 mg/2.5 mg at 2 weeks if necessary. Patients with hypertension underwent 24-h ambulatory BP monitoring (ABPM) at baseline and end of follow-up.

Results

Mean baseline BP values were 146.2/93.1 and 119.1/76.1 mmHg in the hypertension and control groups, respectively. Patients with hypertension had significantly (p < 0.001) lower CBF in the cortical plate of both left (36.2 ± 8.3 vs. 45.3 ± 3.5 ml/100 g/min) and right (37.9 ± 7.9 vs. 45.8 ± 3.2 ml/100 g/min) frontal lobes compared to normotensive controls. At the end of follow-up, there was a statistically significant (p < 0.001) increase in CBF in the cortical plate of both left (from 36.2 ± 8.3 to 47.5 ± 9.8 ml/100 g/min) and right frontal lobes (from 37.9 ± 7.9 to 47.4 ± 10.1 ml/100 g/min) compared to baseline. No significant difference was found between end of follow-up CBF levels in frontal lobes of patients with hypertension and those of healthy controls at baseline. Office BP decreased by 24.2/15.5 mmHg and 24-h ABPM from 145.5/95.3 to 120.8/79.3 mmHg.

Conclusion

In middle-aged, treatment-naïve patients with hypertension, Pa/I SPC was associated with increased CBF in the cortical plate of the frontal lobes, which achieved levels of normotensive controls. The increase in CBF had no clear association with observed BP changes.

Registration number

ISRCTN67799751.
Literatur
1.
Zurück zum Zitat Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRef Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRef
2.
Zurück zum Zitat GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.CrossRef GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.CrossRef
3.
Zurück zum Zitat Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599–606.CrossRef Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599–606.CrossRef
4.
Zurück zum Zitat Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS data brief, no 289. Hyattsville, MD: National Center for Health Statistics (2017). Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS data brief, no 289. Hyattsville, MD: National Center for Health Statistics (2017).
5.
Zurück zum Zitat Pletcher MJ, Vittinghoff E, Thanataveerat A, Bibbins-Domingo K, Moran AE. Young adult exposure to cardiovascular risk factors and risk of events later in life: the Framingham Offspring Study. PLoS One. 2016;11(5):e0154288.CrossRef Pletcher MJ, Vittinghoff E, Thanataveerat A, Bibbins-Domingo K, Moran AE. Young adult exposure to cardiovascular risk factors and risk of events later in life: the Framingham Offspring Study. PLoS One. 2016;11(5):e0154288.CrossRef
6.
Zurück zum Zitat Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396–403.CrossRef Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396–403.CrossRef
7.
Zurück zum Zitat Yiyi Zhang Y, Moran A. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736–42.CrossRef Yiyi Zhang Y, Moran A. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736–42.CrossRef
8.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, et al. 2013ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013ESH;31(7):1281–357.CrossRef Mancia G, Fagard R, Narkiewicz K, et al. 2013ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013ESH;31(7):1281–357.CrossRef
9.
Zurück zum Zitat Buyck J, Dufouil C, Mazoyer B, et al. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke. 2009;40:2327–31.CrossRef Buyck J, Dufouil C, Mazoyer B, et al. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke. 2009;40:2327–31.CrossRef
10.
Zurück zum Zitat Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229–366.CrossRef Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229–366.CrossRef
11.
Zurück zum Zitat Sierra C, Coca C. White matter lesions and cognitive impairment as silent cerebral disease in hypertension. Sci World J. 2006;6:494–501.CrossRef Sierra C, Coca C. White matter lesions and cognitive impairment as silent cerebral disease in hypertension. Sci World J. 2006;6:494–501.CrossRef
12.
Zurück zum Zitat Petcharunpaisan S, Ramalho J, Castillo M. Arterial spin labeling in neuroimaging. World J Radiol. 2010;2(10):384–98.CrossRef Petcharunpaisan S, Ramalho J, Castillo M. Arterial spin labeling in neuroimaging. World J Radiol. 2010;2(10):384–98.CrossRef
13.
Zurück zum Zitat Wang T, Li Y, Guo X, et al. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling. J Magn Reason Imaging. 2016;43(3):635–43.CrossRef Wang T, Li Y, Guo X, et al. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling. J Magn Reason Imaging. 2016;43(3):635–43.CrossRef
14.
Zurück zum Zitat Van Dalen J, Mutsaerts H, Nederveen AJ, et al. White matter hyperintensity volume and cerebral perfusion in older individuals with hypertension using arterial spin-labeling. Am J Neuroradiol. 2016;37:1824–30.CrossRef Van Dalen J, Mutsaerts H, Nederveen AJ, et al. White matter hyperintensity volume and cerebral perfusion in older individuals with hypertension using arterial spin-labeling. Am J Neuroradiol. 2016;37:1824–30.CrossRef
15.
Zurück zum Zitat Bastos-Leite A, Kuijer J, Rombouts S, et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. Am J Neuroradiol. 2008;29:1296–301.CrossRef Bastos-Leite A, Kuijer J, Rombouts S, et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. Am J Neuroradiol. 2008;29:1296–301.CrossRef
16.
Zurück zum Zitat Alosco M, Gunstad J, Xu X, et al. The impact of hypertension on cerebral perfusion and cortical thickness in older adults. J Am Soc Hypertens. 2014;8(8):561–70.CrossRef Alosco M, Gunstad J, Xu X, et al. The impact of hypertension on cerebral perfusion and cortical thickness in older adults. J Am Soc Hypertens. 2014;8(8):561–70.CrossRef
17.
Zurück zum Zitat Tryambake D, He J, Firbank M, et al. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension. 2013;61:1309–15.CrossRef Tryambake D, He J, Firbank M, et al. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension. 2013;61:1309–15.CrossRef
18.
Zurück zum Zitat Ostroumova T, Ostroumova O, Parfenov V, Perepelova E. Increased cerebral blood flow in middle-aged treatment naive hypertensive patients receiving fixed combination treatment with perindopril arginine/indapamide. J Hypertens. 2019;37:e19. Ostroumova T, Ostroumova O, Parfenov V, Perepelova E. Increased cerebral blood flow in middle-aged treatment naive hypertensive patients receiving fixed combination treatment with perindopril arginine/indapamide. J Hypertens. 2019;37:e19.
19.
Zurück zum Zitat Koudryavtcev SA, Lazarev VM. Validation of the BPLab(®) 24-hour blood pressure monitoring system according to the European standard BS EN 1060–4:2004 and British Hypertension Society protocol. Med Devices (Auckl). 2011;4:193–6. Koudryavtcev SA, Lazarev VM. Validation of the BPLab(®) 24-hour blood pressure monitoring system according to the European standard BS EN 1060–4:2004 and British Hypertension Society protocol. Med Devices (Auckl). 2011;4:193–6.
20.
Zurück zum Zitat Launer L, Lewis C, Schreiner P, et al. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study. PLoS One. 2015;10(3):e0122138.CrossRef Launer L, Lewis C, Schreiner P, et al. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study. PLoS One. 2015;10(3):e0122138.CrossRef
21.
Zurück zum Zitat Glodzik L, Rusinek H, Tsui W, et al. Different relationship between systolic blood pressure and cerebral perfusion in subjects with and without hypertension. Hypertension. 2019;73(1):197–205.CrossRef Glodzik L, Rusinek H, Tsui W, et al. Different relationship between systolic blood pressure and cerebral perfusion in subjects with and without hypertension. Hypertension. 2019;73(1):197–205.CrossRef
22.
Zurück zum Zitat Foster-Dingley JC, Moonen JE, de Craen AJ, et al. Blood pressure is not associated with cerebral blood flow in older persons. Hypertension. 2015;66(5):954–60.CrossRef Foster-Dingley JC, Moonen JE, de Craen AJ, et al. Blood pressure is not associated with cerebral blood flow in older persons. Hypertension. 2015;66(5):954–60.CrossRef
23.
Zurück zum Zitat Nam KW, Kwon H, Kwon HM, et al. Abdominal fatness and cerebral white matter hyperintensity. J Neurol Sci. 2019;404:52–7.CrossRef Nam KW, Kwon H, Kwon HM, et al. Abdominal fatness and cerebral white matter hyperintensity. J Neurol Sci. 2019;404:52–7.CrossRef
24.
Zurück zum Zitat Willeumier KC, Taylor DV, Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity (Silver Spring). 2011;19(5):1095–7.CrossRef Willeumier KC, Taylor DV, Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity (Silver Spring). 2011;19(5):1095–7.CrossRef
25.
Zurück zum Zitat MacIntosh BJ, Shirzadi Z, Atwi S, et al. Metabolic and vascular risk factors are associated with reduced cerebral blood flow and poorer midlife memory performance. Hum Brain Map. 2019;41(4):1–10. MacIntosh BJ, Shirzadi Z, Atwi S, et al. Metabolic and vascular risk factors are associated with reduced cerebral blood flow and poorer midlife memory performance. Hum Brain Map. 2019;41(4):1–10.
26.
Zurück zum Zitat Feihl F, Liaudet L, Levy B, Waeber B. Hypertension and microvascular remodeling. Cardiovasc Res. 2008;78(2):274–85.CrossRef Feihl F, Liaudet L, Levy B, Waeber B. Hypertension and microvascular remodeling. Cardiovasc Res. 2008;78(2):274–85.CrossRef
27.
Zurück zum Zitat Mifsud G, Zammit C, Muscat R, Di Giovanni G, Valentino M. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia. CNS Neurosci Therap. 2014;20:603–12.CrossRef Mifsud G, Zammit C, Muscat R, Di Giovanni G, Valentino M. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia. CNS Neurosci Therap. 2014;20:603–12.CrossRef
28.
Zurück zum Zitat Pieniaże W, Dimitrow P, Jasiński T. Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients. Cardiovasc Drugs Ther. 2001;15(1):63–7.CrossRef Pieniaże W, Dimitrow P, Jasiński T. Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients. Cardiovasc Drugs Ther. 2001;15(1):63–7.CrossRef
29.
Zurück zum Zitat Tota S, Nath C, Najmi AK, Shukla R, Hanif K. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Behav Brain Res. 2012;232(1):66–76.CrossRef Tota S, Nath C, Najmi AK, Shukla R, Hanif K. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Behav Brain Res. 2012;232(1):66–76.CrossRef
30.
Zurück zum Zitat Walters M, Muir S, Shah I, Lees K. Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke. 2004;35(8):1899–902.CrossRef Walters M, Muir S, Shah I, Lees K. Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke. 2004;35(8):1899–902.CrossRef
31.
Zurück zum Zitat Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216–21.CrossRef Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216–21.CrossRef
32.
Zurück zum Zitat Walters M, Bolster A, Dyker A, Lees K. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke. 2001;32:473–8.CrossRef Walters M, Bolster A, Dyker A, Lees K. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke. 2001;32:473–8.CrossRef
33.
Zurück zum Zitat Dyker AG, Grosset DG, Lees KR. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischaemic stroke. Stroke. 1997;28:580–3.CrossRef Dyker AG, Grosset DG, Lees KR. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischaemic stroke. Stroke. 1997;28:580–3.CrossRef
34.
Zurück zum Zitat PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–41.CrossRef PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–41.CrossRef
35.
Zurück zum Zitat Hatazawa J, Shimosegawa E, Osaki Y, et al. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. Stroke. 2004;35(9):2117–222.CrossRef Hatazawa J, Shimosegawa E, Osaki Y, et al. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. Stroke. 2004;35(9):2117–222.CrossRef
36.
Zurück zum Zitat Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertens Res. 2004;27(3):147–56.CrossRef Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertens Res. 2004;27(3):147–56.CrossRef
37.
Zurück zum Zitat Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069–75. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069–75.
38.
Zurück zum Zitat Tymko MM, Ainslie PN, Smith KJ. Evaluating the methods used for measuring cerebral blood flow at rest and during exercise in humans. Eur J Appl Physiol. 2018;118(8):1527–38.CrossRef Tymko MM, Ainslie PN, Smith KJ. Evaluating the methods used for measuring cerebral blood flow at rest and during exercise in humans. Eur J Appl Physiol. 2018;118(8):1527–38.CrossRef
39.
Zurück zum Zitat Debbabi H, Bonnin P, Levy BI. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens. 2010;23(10):1136–43.CrossRef Debbabi H, Bonnin P, Levy BI. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens. 2010;23(10):1136–43.CrossRef
Metadaten
Titel
Effect of Perindopril/Indapamide on Cerebral Blood Flow in Middle-Aged, Treatment-Naïve Patients with Hypertension
verfasst von
Tatiana M. Ostroumova
Olga D. Ostroumova
Vladimir A. Parfenov
Elena M. Perepelova
Vsevolod A. Perepelov
Alexey I. Kochetkov
Publikationsdatum
07.10.2020
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 12/2020
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-020-01515-7

Weitere Artikel der Ausgabe 12/2020

Advances in Therapy 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.